DECEMBER 2 |
COVID-19 and the Role of Diagnostic Testing for Asymptomatic and Pre-Symptomatic Individuals |
OCTOBER 29 |
|
OCTOBER 9 |
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine |
OCTOBER 1 |
19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortium |
AUGUST 7 |
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan |
AUGUST 3 |
|
MAY 26 |
|
MAY 7 |
|
APRIL 6 |
|
MARCH 25 |
|
MARCH 23 |
|
MARCH 4 |
Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19 |